Dovel Technologies Awarded Biologics Surveillance IDIQ

Thursday, October 25, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Company received two IDIQs to help build a data ecosystem and tools in support of biologic product safety

MCLEAN, Va., Oct. 25, 2018 /PRNewswire-PRWeb/ -- Dovel Technologies announced today they have been awarded two IDIQs

from the Food and Drug Administration (FDA) Center for Biologics Effectiveness and Research (CBER) for the CBER Biologics Effectiveness and Safety (BEST) Initiative. The program will help CBER expand and enhance current capabilities with respect to data sources, infrastructure, methods, and tools and to conduct active surveillance, epidemiologic studies and automated reporting to improve the the safety and efficacy of biologic products including vaccines, blood and blood products, tissues, and advanced therapeutics.

"We are excited to get to work helping build the data strategy and tools that will enhance CBER's efficiency in meeting their mission to assure the safety and efficacy of biologic products," said Dovel COO, Damon Griggs. "Our team has exciting and innovative approaches and solutions for data science and automation using machine learning, natural language processing, and more to meet the needs of CBER."

Dovel has been awarded two separate IDIQs; Data, Tools and Infrastructure for Surveillance of Biologics as well as Development of New and Innovative Methods for Automated Reporting for CBER-Regulated Biological Products.

Dovel secured one of four awards for each of these five-year IDIQs. Each award has a ceiling of $75 million. Dovel is supported by a collaborative team that brings significant breadth and depth including access to leading national data sources of claims and EHR data, biostatistics and epidemiology as well as expertise in machine learning, natural language processing and Artificial Intelligence.

The awards expand Dovel's work with CBER. The company has been supporting the agency's Laboratory Information Management System (LIMS) development, integration, and deployments since 2011.

About Dovel Technologies Dovel advances the mission of its customers in health, life sciences, and grants management through the integration of technology and domain expertise and delivers complex systems integration and information management technology solutions for highly complex and data-driven environments. To learn more visit http://www.doveltech.com.

Contact: Piper Conrad piper.conrad@gmail.com 571-499-3718

 

SOURCE Dovel Technologies



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store